HScore for Reactive Hemophagocytic Syndrome
Why Use
HPS and HLH have a high fatality rate if not rapidly identified and treated. This score utilizes a mix of clinical and laboratory findings to help predict this rare diagnosis.
When to Use
In adult patients in whom hemophagocytic syndromes (HPS), including hemophagocytic lymphohistiocytosis (HLH), are suspected. Further validation is needed in children; it is not recommended for use in this population.
Formula
Management
Management of HPS and HLH includes identifying and treating the disease trigger and following the clinical protocols set out by the Histiocyte Society . Two commonly referenced protocols include HLH-94 and HLH-2004. Portions of the HLH-2004 protocol are still being studied, and HLH-94 is the more frequently utilized protocol. Prompt consultation with a specialist in HLH is recommended.
More Information
Interpretation: HScore Probability of hemophagocytic syndrome ≤90 <1% 91-100 ~1% 101-110 1-3% 111-120 3-5% 121-130 5-9% 131-140 9-16% 141-150 16-25% 151-160 25-40% 161-170 40-54% 171-180 54-70% 181-190 70-80% 191-200 80-88% 201-210 88-93% 211-220 93-96% 221-230 96-98% 231-240 98-99% ≥241 >99% Note: the best cutoff value for the HScore was 169, corresponding to a sensitivity of 93%, specificity of 86%, and accurate classification of 90% of patients.